false2023Q112/31000010182900001018292023-01-012023-03-310000101829us-gaap:CommonStockMember2023-01-012023-03-310000101829rtx:Notes2.150Due2030Member2023-01-012023-03-3100001018292023-03-31xbrli:shares0000101829us-gaap:ProductMember2023-01-012023-03-31iso4217:USD0000101829us-gaap:ProductMember2022-01-012022-03-310000101829us-gaap:ServiceMember2023-01-012023-03-310000101829us-gaap:ServiceMember2022-01-012022-03-3100001018292022-01-012022-03-31iso4217:USDxbrli:shares00001018292022-12-3100001018292021-12-3100001018292022-03-310000101829us-gaap:CommonStockMember2022-12-310000101829us-gaap:CommonStockMember2021-12-310000101829us-gaap:CommonStockMember2023-01-012023-03-310000101829us-gaap:CommonStockMember2022-01-012022-03-310000101829us-gaap:CommonStockMember2023-03-310000101829us-gaap:CommonStockMember2022-03-310000101829us-gaap:TreasuryStockMember2022-12-310000101829us-gaap:TreasuryStockMember2021-12-310000101829us-gaap:TreasuryStockMember2023-01-012023-03-310000101829us-gaap:TreasuryStockMember2022-01-012022-03-310000101829us-gaap:TreasuryStockMember2023-03-310000101829us-gaap:TreasuryStockMember2022-03-310000101829us-gaap:RetainedEarningsMember2022-12-310000101829us-gaap:RetainedEarningsMember2021-12-310000101829us-gaap:RetainedEarningsMember2023-01-012023-03-310000101829us-gaap:RetainedEarningsMember2022-01-012022-03-310000101829us-gaap:RetainedEarningsMember2023-03-310000101829us-gaap:RetainedEarningsMember2022-03-310000101829us-gaap:DeferredCompensationShareBasedPaymentsMember2022-12-310000101829us-gaap:DeferredCompensationShareBasedPaymentsMember2021-12-310000101829us-gaap:DeferredCompensationShareBasedPaymentsMember2023-01-012023-03-310000101829us-gaap:DeferredCompensationShareBasedPaymentsMember2022-01-012022-03-310000101829us-gaap:DeferredCompensationShareBasedPaymentsMember2023-03-310000101829us-gaap:DeferredCompensationShareBasedPaymentsMember2022-03-310000101829us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000101829us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000101829us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000101829us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000101829us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000101829us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000101829us-gaap:NoncontrollingInterestMember2022-12-310000101829us-gaap:NoncontrollingInterestMember2021-12-310000101829us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000101829us-gaap:NoncontrollingInterestMember2022-01-012022-03-310000101829us-gaap:NoncontrollingInterestMember2023-03-310000101829us-gaap:NoncontrollingInterestMember2022-03-310000101829rtx:RussiaSanctionsImpactOnPrattWhitneyAndCollinsMember2022-01-012022-03-310000101829rtx:CollinsAerospaceMember2022-12-310000101829rtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:CollinsAerospaceMember2023-03-310000101829rtx:PrattAndWhitneyMember2022-12-310000101829rtx:PrattAndWhitneyMember2023-01-012023-03-310000101829rtx:PrattAndWhitneyMember2023-03-310000101829rtx:RaytheonIntelligenceSpaceMember2022-12-310000101829rtx:RaytheonIntelligenceSpaceMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMember2023-03-310000101829rtx:RaytheonMissilesDefenseMember2022-12-310000101829rtx:RaytheonMissilesDefenseMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMember2023-03-310000101829rtx:TotalSegmentsMember2022-12-310000101829rtx:TotalSegmentsMember2023-01-012023-03-310000101829rtx:TotalSegmentsMember2023-03-310000101829rtx:EliminationsAndOtherMember2022-12-310000101829rtx:EliminationsAndOtherMember2023-01-012023-03-310000101829rtx:EliminationsAndOtherMember2023-03-310000101829rtx:CollaborationMember2023-03-310000101829rtx:CollaborationMember2022-12-310000101829rtx:ExclusivityAssetsMember2023-03-310000101829rtx:ExclusivityAssetsMember2022-12-310000101829us-gaap:DevelopedTechnologyRightsMember2023-03-310000101829us-gaap:DevelopedTechnologyRightsMember2022-12-310000101829us-gaap:CustomerRelationshipsMember2023-03-310000101829us-gaap:CustomerRelationshipsMember2022-12-310000101829us-gaap:ContractsAccountedForUnderPercentageOfCompletionMember2023-01-012023-03-310000101829us-gaap:ContractsAccountedForUnderPercentageOfCompletionMember2022-01-012022-03-310000101829rtx:RevolvingCreditAgreementMember2023-03-310000101829rtx:A20BSeptemberRevolvingCreditAgreementMember2023-03-31xbrli:pure0000101829rtx:Notes5000Due2026Member2023-03-310000101829rtx:Notes5000Due2026Member2023-01-012023-03-310000101829rtx:Notes5150Due2033Member2023-03-310000101829rtx:Notes5150Due2033Member2023-01-012023-03-310000101829rtx:Notes5375Due2053Member2023-03-310000101829rtx:Notes5375Due2053Member2023-01-012023-03-310000101829rtx:Notes3.650Due2023Member2023-03-310000101829rtx:Notes3.650Due2023Member2023-01-012023-03-310000101829rtx:Notes3.650Due2023Member2022-12-310000101829rtx:Notes3.700Due2023Member2023-03-310000101829rtx:Notes3.700Due2023Member2023-01-012023-03-310000101829rtx:Notes3.700Due2023Member2022-12-310000101829rtx:Notes3.200Due2024Member2023-03-310000101829rtx:Notes3.200Due2024Member2023-01-012023-03-310000101829rtx:Notes3.200Due2024Member2022-12-310000101829rtx:Notes3150Due2024Member2023-03-310000101829rtx:Notes3150Due2024Member2023-01-012023-03-310000101829rtx:Notes3150Due2024Member2022-12-310000101829rtx:Notes3.950Due2025Member2023-03-310000101829rtx:Notes3.950Due2025Member2023-01-012023-03-310000101829rtx:Notes3.950Due2025Member2022-12-310000101829rtx:Notes2.650Due2026Member2023-03-310000101829rtx:Notes2.650Due2026Member2023-01-012023-03-310000101829rtx:Notes2.650Due2026Member2022-12-310000101829rtx:Notes5000Due2026Member2022-12-310000101829rtx:Notes3.125Due2027Member2023-03-310000101829rtx:Notes3.125Due2027Member2023-01-012023-03-310000101829rtx:Notes3.125Due2027Member2022-12-310000101829rtx:Notes3.500Due2027Member2023-03-310000101829rtx:Notes3.500Due2027Member2023-01-012023-03-310000101829rtx:Notes3.500Due2027Member2022-12-310000101829rtx:Notes7200Due2027Member2023-03-310000101829rtx:Notes7200Due2027Member2023-01-012023-03-310000101829rtx:Notes7200Due2027Member2022-12-310000101829rtx:Notes7100Due2027Member2023-03-310000101829rtx:Notes7100Due2027Member2023-01-012023-03-310000101829rtx:Notes7100Due2027Member2022-12-310000101829rtx:Notes6700Due2028Member2023-03-310000101829rtx:Notes6700Due2028Member2023-01-012023-03-310000101829rtx:Notes6700Due2028Member2022-12-310000101829rtx:Notes7000Due2028Member2023-03-310000101829rtx:Notes7000Due2028Member2023-01-012023-03-310000101829rtx:Notes7000Due2028Member2022-12-310000101829rtx:Notes4.125Due2028Member2023-03-310000101829rtx:Notes4.125Due2028Member2023-01-012023-03-310000101829rtx:Notes4.125Due2028Member2022-12-310000101829rtx:Notes7500Due2029Member2023-03-310000101829rtx:Notes7500Due2029Member2023-01-012023-03-310000101829rtx:Notes7500Due2029Member2022-12-310000101829rtx:Notes2.150Due2030Member2023-03-310000101829rtx:Notes2.150Due2030Member2023-01-012023-03-31iso4217:EUR0000101829rtx:Notes2.150Due2030Member2022-12-310000101829rtx:Notes2250Due2030Member2023-03-310000101829rtx:Notes2250Due2030Member2023-01-012023-03-310000101829rtx:Notes2250Due2030Member2022-12-310000101829rtx:Notes1900Due2031Member2023-03-310000101829rtx:Notes1900Due2031Member2023-01-012023-03-310000101829rtx:Notes1900Due2031Member2022-12-310000101829rtx:Notes2375Due2032Member2023-03-310000101829rtx:Notes2375Due2032Member2023-01-012023-03-310000101829rtx:Notes2375Due2032Member2022-12-310000101829rtx:Notes5150Due2033Member2022-12-310000101829rtx:Notes5400Due2035Member2023-03-310000101829rtx:Notes5400Due2035Member2023-01-012023-03-310000101829rtx:Notes5400Due2035Member2022-12-310000101829rtx:Notes6050Due2036Member2023-03-310000101829rtx:Notes6050Due2036Member2023-01-012023-03-310000101829rtx:Notes6050Due2036Member2022-12-310000101829rtx:Notes6800Due2036Member2023-03-310000101829rtx:Notes6800Due2036Member2023-01-012023-03-310000101829rtx:Notes6800Due2036Member2022-12-310000101829rtx:Notes7000Due2038Member2023-03-310000101829rtx:Notes7000Due2038Member2023-01-012023-03-310000101829rtx:Notes7000Due2038Member2022-12-310000101829rtx:Notes6125Due2038Member2023-03-310000101829rtx:Notes6125Due2038Member2023-01-012023-03-310000101829rtx:Notes6125Due2038Member2022-12-310000101829rtx:Notes4.450Due2038Member2023-03-310000101829rtx:Notes4.450Due2038Member2023-01-012023-03-310000101829rtx:Notes4.450Due2038Member2022-12-310000101829rtx:Notes5700Due2040Member2023-03-310000101829rtx:Notes5700Due2040Member2023-01-012023-03-310000101829rtx:Notes5700Due2040Member2022-12-310000101829rtx:Notes4875Due2040Member2023-03-310000101829rtx:Notes4875Due2040Member2023-01-012023-03-310000101829rtx:Notes4875Due2040Member2022-12-310000101829rtx:Notes4700Due2041Member2023-03-310000101829rtx:Notes4700Due2041Member2023-01-012023-03-310000101829rtx:Notes4700Due2041Member2022-12-310000101829rtx:Notes4500Due2042Member2023-03-310000101829rtx:Notes4500Due2042Member2023-01-012023-03-310000101829rtx:Notes4500Due2042Member2022-12-310000101829rtx:Notes4.800Due2043Member2023-03-310000101829rtx:Notes4.800Due2043Member2023-01-012023-03-310000101829rtx:Notes4.800Due2043Member2022-12-310000101829rtx:Notes4200Due2044Member2023-03-310000101829rtx:Notes4200Due2044Member2023-01-012023-03-310000101829rtx:Notes4200Due2044Member2022-12-310000101829rtx:Notes4.150Due2045MemberMember2023-03-310000101829rtx:Notes4.150Due2045MemberMember2023-01-012023-03-310000101829rtx:Notes4.150Due2045MemberMember2022-12-310000101829rtx:Notes3.750Due2046Member2023-03-310000101829rtx:Notes3.750Due2046Member2023-01-012023-03-310000101829rtx:Notes3.750Due2046Member2022-12-310000101829rtx:Notes4.050Due2047Member2023-03-310000101829rtx:Notes4.050Due2047Member2023-01-012023-03-310000101829rtx:Notes4.050Due2047Member2022-12-310000101829rtx:Notes4.350Due2047Member2023-03-310000101829rtx:Notes4.350Due2047Member2023-01-012023-03-310000101829rtx:Notes4.350Due2047Member2022-12-310000101829rtx:Notes4.625Due2048Member2023-03-310000101829rtx:Notes4.625Due2048Member2023-01-012023-03-310000101829rtx:Notes4.625Due2048Member2022-12-310000101829rtx:Notes3125Due2050Member2023-03-310000101829rtx:Notes3125Due2050Member2023-01-012023-03-310000101829rtx:Notes3125Due2050Member2022-12-310000101829rtx:Notes2820Due2051Member2023-03-310000101829rtx:Notes2820Due2051Member2023-01-012023-03-310000101829rtx:Notes2820Due2051Member2022-12-310000101829rtx:Notes3030Due2052Member2023-03-310000101829rtx:Notes3030Due2052Member2023-01-012023-03-310000101829rtx:Notes3030Due2052Member2022-12-310000101829rtx:Notes5375Due2053Member2022-12-310000101829country:US2023-01-012023-03-310000101829country:US2022-01-012022-03-310000101829us-gaap:ForeignPlanMember2023-01-012023-03-310000101829us-gaap:ForeignPlanMember2022-01-012022-03-310000101829us-gaap:PensionPlansDefinedBenefitMember2023-03-310000101829us-gaap:PensionPlansDefinedBenefitMember2022-12-310000101829us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-03-310000101829us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310000101829us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember2023-03-310000101829us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember2022-12-310000101829us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000101829us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-03-310000101829us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-03-310000101829us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-03-310000101829srt:ScenarioForecastMembersrt:MinimumMember2023-01-012023-12-310000101829srt:ScenarioForecastMembersrt:MaximumMember2023-01-012023-12-310000101829srt:MinimumMember2023-03-310000101829srt:MaximumMember2023-03-310000101829us-gaap:OtherCurrentAssetsMember2023-03-310000101829us-gaap:OtherCurrentAssetsMember2022-12-310000101829us-gaap:AccruedLiabilitiesMember2023-03-310000101829us-gaap:AccruedLiabilitiesMember2022-12-310000101829us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000101829us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000101829us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000101829us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000101829us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000101829us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000101829us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000101829us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000101829us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2023-03-310000101829us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2022-12-310000101829rtx:InternationalAeroEnginesAGMember2023-01-012023-03-310000101829rtx:InternationalAeroEnginesLLCMember2023-01-012023-03-310000101829us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-03-310000101829us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-12-310000101829rtx:CommercialAerospaceFinancingArrangementsMember2023-03-310000101829rtx:CommercialAerospaceFinancingArrangementsMember2022-12-310000101829rtx:ThirdPartyGuaranteesMember2023-03-310000101829rtx:ThirdPartyGuaranteesMember2022-12-310000101829rtx:CommercialAerospaceMember2023-03-310000101829rtx:CommercialAerospaceMember2022-12-310000101829us-gaap:GuaranteeTypeOtherMember2023-03-310000101829us-gaap:GuaranteeTypeOtherMember2022-12-310000101829rtx:CommercialAerospaceMember2023-03-310000101829rtx:CommercialAerospaceMember2022-12-310000101829rtx:OtherFinancingArrangementsMember2023-03-310000101829rtx:A2019USDefenseContractManagementAgencyClaimAgainstPrattWhitneyMember2023-01-012023-03-310000101829rtx:U.S.DefenseContractManagementAgencyClaimAgainstPrattWhitneyMember2023-01-012023-03-310000101829rtx:U.S.DefenseContractManagementAgencyClaimAgainstPrattWhitneysecondclaimMember2023-01-012023-03-310000101829rtx:DepartmentOfJusticeClaimAgainstRaytheonMissilesDefenseMember2023-01-012023-03-310000101829us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000101829us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000101829us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000101829us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000101829us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000101829us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000101829us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000101829us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000101829us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000101829us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000101829us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310000101829us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-03-310000101829rtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:PrattAndWhitneyMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMember2022-01-012022-03-310000101829us-gaap:OperatingSegmentsMember2023-01-012023-03-310000101829us-gaap:OperatingSegmentsMember2022-01-012022-03-310000101829us-gaap:IntersegmentEliminationMember2023-01-012023-03-310000101829us-gaap:IntersegmentEliminationMember2022-01-012022-03-310000101829us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000101829us-gaap:CorporateNonSegmentMember2022-01-012022-03-310000101829us-gaap:MaterialReconcilingItemsMemberrtx:FASCASOperatingAdjustmentMember2023-01-012023-03-310000101829us-gaap:MaterialReconcilingItemsMemberrtx:FASCASOperatingAdjustmentMember2022-01-012022-03-310000101829us-gaap:MaterialReconcilingItemsMemberrtx:AcquisitionAccountingAdjustmentMemberMember2023-01-012023-03-310000101829us-gaap:MaterialReconcilingItemsMemberrtx:AcquisitionAccountingAdjustmentMemberMember2022-01-012022-03-310000101829country:USrtx:CollinsAerospaceMember2023-01-012023-03-310000101829country:USrtx:PrattAndWhitneyMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMembercountry:US2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMembercountry:US2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMembercountry:US2023-01-012023-03-310000101829country:US2023-01-012023-03-310000101829country:USrtx:CollinsAerospaceMember2022-01-012022-03-310000101829country:USrtx:PrattAndWhitneyMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMembercountry:US2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMembercountry:US2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMembercountry:US2022-01-012022-03-310000101829country:US2022-01-012022-03-310000101829srt:EuropeMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829srt:EuropeMemberrtx:PrattAndWhitneyMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMembersrt:EuropeMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMembersrt:EuropeMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMembersrt:EuropeMember2023-01-012023-03-310000101829srt:EuropeMember2023-01-012023-03-310000101829srt:EuropeMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829srt:EuropeMemberrtx:PrattAndWhitneyMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMembersrt:EuropeMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMembersrt:EuropeMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMembersrt:EuropeMember2022-01-012022-03-310000101829srt:EuropeMember2022-01-012022-03-310000101829srt:AsiaPacificMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:PrattAndWhitneyMembersrt:AsiaPacificMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMembersrt:AsiaPacificMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMembersrt:AsiaPacificMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMembersrt:AsiaPacificMember2023-01-012023-03-310000101829srt:AsiaPacificMember2023-01-012023-03-310000101829srt:AsiaPacificMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:PrattAndWhitneyMembersrt:AsiaPacificMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMembersrt:AsiaPacificMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMembersrt:AsiaPacificMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMembersrt:AsiaPacificMember2022-01-012022-03-310000101829srt:AsiaPacificMember2022-01-012022-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMemberrtx:PrattAndWhitneyMember2023-01-012023-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMemberrtx:RaytheonIntelligenceSpaceMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:MiddleEastAndNorthAfricaMemberMember2023-01-012023-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMemberus-gaap:AllOtherSegmentsMember2023-01-012023-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMember2023-01-012023-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMemberrtx:PrattAndWhitneyMember2022-01-012022-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMemberrtx:RaytheonIntelligenceSpaceMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:MiddleEastAndNorthAfricaMemberMember2022-01-012022-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMemberus-gaap:AllOtherSegmentsMember2022-01-012022-03-310000101829rtx:MiddleEastAndNorthAfricaMemberMember2022-01-012022-03-310000101829rtx:OtherMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:PrattAndWhitneyMemberrtx:OtherMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMemberrtx:OtherMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:OtherMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMemberrtx:OtherMember2023-01-012023-03-310000101829rtx:OtherMember2023-01-012023-03-310000101829rtx:OtherMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:PrattAndWhitneyMemberrtx:OtherMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMemberrtx:OtherMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:OtherMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMemberrtx:OtherMember2022-01-012022-03-310000101829rtx:OtherMember2022-01-012022-03-310000101829us-gaap:OperatingSegmentsMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:PrattAndWhitneyMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000101829us-gaap:OperatingSegmentsMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:PrattAndWhitneyMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000101829us-gaap:IntersegmentEliminationMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829us-gaap:IntersegmentEliminationMemberrtx:PrattAndWhitneyMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMember2023-01-012023-03-310000101829us-gaap:IntersegmentEliminationMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829us-gaap:IntersegmentEliminationMemberrtx:PrattAndWhitneyMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMemberus-gaap:IntersegmentEliminationMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:IntersegmentEliminationMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMember2022-01-012022-03-310000101829rtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:PrattAndWhitneyMemberrtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMemberrtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMemberrtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2023-01-012023-03-310000101829rtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2023-01-012023-03-310000101829rtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:PrattAndWhitneyMemberrtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMemberrtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMemberrtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2022-01-012022-03-310000101829rtx:USGovernmentSalesExcludingForeignMilitarySalesMemberMember2022-01-012022-03-310000101829rtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:PrattAndWhitneyMemberrtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMemberrtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMemberrtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2023-01-012023-03-310000101829rtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2023-01-012023-03-310000101829rtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:PrattAndWhitneyMemberrtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMemberrtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMemberrtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2022-01-012022-03-310000101829rtx:ForeignMilitarySalesThroughTheUSGovernmentMemberMember2022-01-012022-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberrtx:PrattAndWhitneyMember2023-01-012023-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberrtx:RaytheonIntelligenceSpaceMember2023-01-012023-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberrtx:RaytheonMissilesDefenseMember2023-01-012023-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberus-gaap:AllOtherSegmentsMember2023-01-012023-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMember2023-01-012023-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberrtx:PrattAndWhitneyMember2022-01-012022-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberrtx:RaytheonIntelligenceSpaceMember2022-01-012022-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberrtx:RaytheonMissilesDefenseMember2022-01-012022-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMemberus-gaap:AllOtherSegmentsMember2022-01-012022-03-310000101829rtx:ForeignGovernmentDirectCommercialSalesMemberMember2022-01-012022-03-310000101829rtx:CommercialAerospaceAndOtherCommercialMemberMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829rtx:CommercialAerospaceAndOtherCommercialMemberMemberrtx:PrattAndWhitneyMember2023-01-012023-03-310000101829rtx:CommercialAerospaceAndOtherCommercialMemberMemberrtx:RaytheonIntelligenceSpaceMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:CommercialAerospaceAndOtherCommercialMemberMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMemberrtx:CommercialAerospaceAndOtherCommercialMemberMember2023-01-012023-03-310000101829rtx:CommercialAerospaceAndOtherCommercialMemberMember2023-01-012023-03-310000101829rtx:CommercialAerospaceAndOtherCommercialMemberMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829rtx:CommercialAerospaceAndOtherCommercialMemberMemberrtx:PrattAndWhitneyMember2022-01-012022-03-310000101829rtx:CommercialAerospaceAndOtherCommercialMemberMemberrtx:RaytheonIntelligenceSpaceMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberrtx:CommercialAerospaceAndOtherCommercialMemberMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMemberrtx:CommercialAerospaceAndOtherCommercialMemberMember2022-01-012022-03-310000101829rtx:CommercialAerospaceAndOtherCommercialMemberMember2022-01-012022-03-310000101829us-gaap:ProductMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829us-gaap:ProductMemberrtx:PrattAndWhitneyMember2023-01-012023-03-310000101829us-gaap:ProductMemberrtx:RaytheonIntelligenceSpaceMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:ProductMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMemberus-gaap:ProductMember2023-01-012023-03-310000101829us-gaap:ProductMember2023-01-012023-03-310000101829us-gaap:ProductMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829us-gaap:ProductMemberrtx:PrattAndWhitneyMember2022-01-012022-03-310000101829us-gaap:ProductMemberrtx:RaytheonIntelligenceSpaceMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:ProductMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMemberus-gaap:ProductMember2022-01-012022-03-310000101829us-gaap:ProductMember2022-01-012022-03-310000101829us-gaap:ServiceMemberrtx:CollinsAerospaceMember2023-01-012023-03-310000101829us-gaap:ServiceMemberrtx:PrattAndWhitneyMember2023-01-012023-03-310000101829us-gaap:ServiceMemberrtx:RaytheonIntelligenceSpaceMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:ServiceMember2023-01-012023-03-310000101829us-gaap:AllOtherSegmentsMemberus-gaap:ServiceMember2023-01-012023-03-310000101829us-gaap:ServiceMember2023-01-012023-03-310000101829us-gaap:ServiceMemberrtx:CollinsAerospaceMember2022-01-012022-03-310000101829us-gaap:ServiceMemberrtx:PrattAndWhitneyMember2022-01-012022-03-310000101829us-gaap:ServiceMemberrtx:RaytheonIntelligenceSpaceMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:ServiceMember2022-01-012022-03-310000101829us-gaap:AllOtherSegmentsMemberus-gaap:ServiceMember2022-01-012022-03-310000101829us-gaap:ServiceMember2022-01-012022-03-310000101829rtx:RaytheonIntelligenceSpaceMemberus-gaap:FixedPriceContractMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:FixedPriceContractMember2023-01-012023-03-310000101829rtx:RaytheonIntelligenceSpaceMemberus-gaap:FixedPriceContractMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:FixedPriceContractMember2022-01-012022-03-310000101829us-gaap:TimeAndMaterialsContractMemberrtx:RaytheonIntelligenceSpaceMember2023-01-012023-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:TimeAndMaterialsContractMember2023-01-012023-03-310000101829us-gaap:TimeAndMaterialsContractMemberrtx:RaytheonIntelligenceSpaceMember2022-01-012022-03-310000101829rtx:RaytheonMissilesDefenseMemberus-gaap:TimeAndMaterialsContractMember2022-01-012022-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
____________________________________
FORM 10-Q
____________________________________ | | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2023
OR | | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 001-00812
____________________________________
RAYTHEON TECHNOLOGIES CORPORATION
(Exact name of registrant as specified in its charter)
____________________________________ | | | | | | | | |
Delaware | | 06-0570975 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | | | | | | | | | | |
1000 Wilson Boulevard, | Arlington, | Virginia | 22209 |
(Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | | | | |
Title of each class | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock ($1 par value) | RTX | | New York Stock Exchange |
(CUSIP 75513E 101) | | | |
2.150% Notes due 2030 | RTX 30 | | New York Stock Exchange |
(CUSIP 75513E AB7) | | | |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒. No ☐.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒. No ☐.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. | | | | | | | | | | | |
Large Accelerated Filer | ☒ | Accelerated Filer | ☐ |
| | | |
Non-accelerated Filer | ☐ | Smaller Reporting Company | ☐ |
| | | |
| | Emerging Growth Company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐. No ☒.
At March 31, 2023 there were 1,461,142,016 shares of Common Stock outstanding.
RAYTHEON TECHNOLOGIES CORPORATION
AND SUBSIDIARIES
CONTENTS OF QUARTERLY REPORT ON FORM 10-Q
Quarter Ended March 31, 2023
Raytheon Technologies Corporation and its subsidiaries’ names, abbreviations thereof, logos, and products and services designators are all either the registered or unregistered trademarks or tradenames of Raytheon Technologies Corporation and its subsidiaries. Names, abbreviations of names, logos, and products and services designators of other companies are either the registered or unregistered trademarks or tradenames of their respective owners. References to internet web sites in this Form 10-Q are provided for convenience only. Information available through these web sites is not incorporated by reference into this Form 10-Q.
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
RAYTHEON TECHNOLOGIES CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(Unaudited) | | | | | | | | | | | | | | | |
| Quarter Ended March 31, | | |
(dollars in millions, except per share amounts) | 2023 | | 2022 | | | | |
Net Sales: | | | | | | | |
Products sales | $ | 12,787 | | | $ | 11,862 | | | | | |
Services sales | 4,427 | | | 3,854 | | | | | |
Total net sales | 17,214 | | | 15,716 | | | | | |
Costs and Expenses: | | | | | | | |
Cost of sales - products | 10,700 | | | 9,820 | | | | | |
Cost of sales - services | 2,945 | | | 2,740 | | | | | |
Research and development | 607 | | | 635 | | | | | |
Selling, general and administrative | 1,398 | | | 1,469 | | | | | |
Total costs and expenses | 15,650 | | | 14,664 | | | | | |
| | | | | | | |
Other income, net | 88 | | | 28 | | | | | |
Operating profit | 1,652 | | | 1,080 | | | | | |
Non-operating expense (income), net: | | | | | | | |
Non-service pension income | (444) | | | (480) | | | | | |
Interest expense, net | 315 | | | 318 | | | | | |
Total non-operating expense (income), net | (129) | | | (162) | | | | | |
Income from continuing operations before income taxes | 1,781 | | | 1,242 | | | | | |
Income tax expense | 300 | | | 116 | | | | | |
Net income from continuing operations | 1,481 | | | 1,126 | | | | | |
Less: Noncontrolling interest in subsidiaries’ earnings from continuing operations | 55 | | | 23 | | | | | |
Net income from continuing operations attributable to common shareowners | 1,426 | | | 1,103 | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Loss from discontinued operations attributable to common shareowners | — | | | (19) | | | | | |
Net income attributable to common shareowners | $ | 1,426 | | | $ | 1,084 | | | | | |
| | | | | | | |
Earnings (loss) Per Share attributable to common shareowners - Basic: | | | | | | | |
Income from continuing operations | $ | 0.98 | | | $ | 0.74 | | | | | |
Loss from discontinued operations | — | | | (0.01) | | | | | |
Net income attributable to common shareowners | $ | 0.98 | | | $ | 0.73 | | | | | |
Earnings (loss) Per Share attributable to common shareowners - Diluted: | | | | | | | |
Income from continuing operations | $ | 0.97 | | | $ | 0.74 | | | | | |
Loss from discontinued operations | — | | | (0.02) | | | | | |
Net income attributable to common shareowners | $ | 0.97 | | | $ | 0.72 | | | | | |
See accompanying Notes to Condensed Consolidated Financial Statements
RAYTHEON TECHNOLOGIES CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(Unaudited)
| | | | | | | | | | | | | | | |
| Quarter Ended March 31, | | |
(dollars in millions) | 2023 | | 2022 | | | | |
Net income from continuing and discontinued operations | $ | 1,481 | | | $ | 1,107 | | | | | |
Other comprehensive income (loss), before tax: | | | | | | | |
Foreign currency translation adjustments | 122 | | | (240) | | | | | |
Pension and postretirement benefit plans adjustments | (146) | | | 21 | | | | | |
Change in unrealized cash flow hedging | 12 | | | 37 | | | | | |
Other comprehensive income (loss), before tax | (12) | | | (182) | | | | | |
Income tax (expense) benefit related to items of other comprehensive income (loss) | 41 | | | (18) | | | | | |
Other comprehensive income (loss), net of tax | 29 | | | (200) | | | | | |
Comprehensive income | 1,510 | | | 907 | | | | | |
Less: Comprehensive income attributable to noncontrolling interest | 55 | | | 23 | | | | | |
Comprehensive income attributable to common shareowners | $ | 1,455 | | | $ | 884 | | | | | |
See accompanying Notes to Condensed Consolidated Financial Statements
RAYTHEON TECHNOLOGIES CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET
(Unaudited) | | | | | | | | | | | |
(dollars in millions) | March 31, 2023 | | December 31, 2022 |
Assets | | | |
Current Assets | | | |
Cash and cash equivalents | $ | 5,893 | | | $ | 6,220 | |
Accounts receivable, net | 10,069 | | | 9,108 | |
Contract assets | 12,729 | | | 11,534 | |
Inventory, net | 11,327 | | | 10,617 | |
| | | |
Other assets, current | 5,486 | | | 4,964 | |
Total current assets | 45,504 | | | 42,443 | |
Customer financing assets | 2,543 | | | 2,603 | |
Fixed assets | 29,536 | | | 29,116 | |
Accumulated depreciation | (14,387) | | | (13,946) | |
Fixed assets, net | 15,149 | | | 15,170 | |
Operating lease right-of-use assets | 1,844 | | | 1,829 | |
Goodwill | 53,904 | | | 53,840 | |
Intangible assets, net | 36,477 | | | 36,823 | |
Other assets | 6,215 | | | 6,156 | |
Total assets | $ | 161,636 | | | $ | 158,864 | |
Liabilities, Redeemable Noncontrolling Interest and Equity | | | |
Current Liabilities | | | |
Short-term borrowings | $ | 224 | | | $ | 625 | |
Accounts payable | 10,060 | | | 9,896 | |
Accrued employee compensation | 1,856 | | | 2,401 | |
Other accrued liabilities | 11,573 | | | 10,999 | |
Contract liabilities | 14,870 | | | 14,598 | |
| | | |
Long-term debt currently due | 1,545 | | | 595 | |
Total current liabilities | 40,128 | | | 39,114 | |
Long-term debt | 32,717 | | | 30,694 | |
Operating lease liabilities, non-current | 1,624 | | | 1,586 | |
Future pension and postretirement benefit obligations | 4,676 | | | 4,807 | |
Other long-term liabilities | 8,106 | | | 8,449 | |
Total liabilities | 87,251 | | | 84,650 | |
Commitments and contingencies (Note 15) | | | |
Redeemable noncontrolling interest | 38 | | | 36 | |
Shareowners’ Equity: | | | |
Common stock | 38,031 | | | 37,939 | |
Treasury stock | (16,112) | | | (15,530) | |
Retained earnings | 52,891 | | | 52,269 | |
Unearned ESOP shares | (26) | | | (28) | |
Accumulated other comprehensive loss | (1,989) | | | (2,018) | |
Total shareowners’ equity | 72,795 | | | 72,632 | |
Noncontrolling interest | 1,552 | | | 1,546 | |
Total equity | 74,347 | | | 74,178 | |
Total liabilities, redeemable noncontrolling interest and equity | $ | 161,636 | | | $ | 158,864 | |
See accompanying Notes to Condensed Consolidated Financial Statements
RAYTHEON TECHNOLOGIES CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Unaudited) | | | | | | | | | | | |
| Quarter Ended March 31, |
(dollars in millions) | 2023 | | 2022 |
Operating Activities: | | | |
Net income from continuing operations | $ | 1,481 | | | $ | 1,126 | |
Adjustments to reconcile net income from continuing operations to net cash flows (used in) provided by operating activities: | | | |
Depreciation and amortization | 1,034 | | | 1,014 | |
Deferred income tax benefit | (329) | | | (601) | |
Stock compensation cost | 100 | | | 103 | |
Net periodic pension and other postretirement income | (388) | | | (360) | |
| | | |
Change in: | | | |
Accounts receivable | (962) | | | 556 | |
Contract assets | (1,198) | | | (219) | |
Inventory | (720) | | | (587) | |
Other current assets | (526) | | | (281) | |
Accounts payable and accrued liabilities | 490 | | | (316) | |
Contract liabilities | 223 | | | (50) | |
| | | |
Other operating activities, net | (68) | | | 91 | |
Net cash flows (used in) provided by operating activities from continuing operations | (863) | | | 476 | |
Investing Activities: | | | |
Capital expenditures | (520) | | | (439) | |
| | | |
Dispositions of businesses, net of cash transferred | — | | | 35 | |
Customer financing assets receipts (payments), net | 28 | | | (19) | |
Increase in other intangible assets | (154) | | | (82) | |
Payments from settlements of derivative contracts, net | (13) | | | (33) | |
Other investing activities, net | 80 | | | 20 | |
Net cash flows used in investing activities from continuing operations | (579) | | | (518) | |
Financing Activities: | | | |
Issuance of long-term debt | 2,971 | | | — | |
| | | |
| | | |
Change in commercial paper, net (Note 8) | (427) | | | — | |
Change in other short-term borrowings, net | 22 | | | 6 | |
| | | |
Dividends paid on common stock | (790) | | | (745) | |
Repurchase of common stock | (562) | | | (743) | |
| | | |
Other financing activities, net | (118) | | | (263) | |
Net cash flows provided by (used in) financing activities from continuing operations | 1,096 | | | (1,745) | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Effect of foreign exchange rate changes on cash and cash equivalents | 1 | | | 15 | |
| | | |
Net decrease in cash, cash equivalents and restricted cash | (345) | | | (1,772) | |
Cash, cash equivalents and restricted cash, beginning of period | 6,291 | | | 7,853 | |
| | | |
Cash, cash equivalents and restricted cash, end of period | 5,946 | | | 6,081 | |
Less: Restricted cash, included in Other assets, current and Other assets | 53 | | | 41 | |
| | | |
Cash and cash equivalents, end of period | $ | 5,893 | | | $ | 6,040 | |
See accompanying Notes to Condensed Consolidated Financial Statements
RAYTHEON TECHNOLOGIES CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
(Unaudited) | | | | | | | | | | | | | | | |
| Quarter Ended March 31, | | |
(dollars in millions, except per share amounts; shares in thousands) | 2023 | | 2022 | | | | |
Equity beginning balance | $ | 74,178 | | | $ | 74,664 | | | | | |
Common Stock | | | | | | | |
Beginning balance | 37,939 | | | 37,483 | | | | | |
Common stock plans activity | 92 | | | 34 | | | | | |
Purchase of subsidiary shares from noncontrolling interest, net | — | | | (13) | | | | | |
Ending balance | 38,031 | | | 37,504 | | | | | |
Treasury Stock | | | | | | | |
Beginning balance | (15,530) | | | (12,727) | | | | | |
| | | | | | | |
Common stock repurchased | (582) | | | (756) | | | | | |
| | | | | | | |
Ending balance | (16,112) | | | (13,483) | | | | | |
Retained Earnings | | | | | | | |
Beginning balance | 52,269 | | | 50,265 | | | | | |
Net income | 1,426 | | | 1,084 | | | | | |
Dividends on common stock | (790) | | | (745) | | | | | |
Dividends on ESOP common stock | (13) | | | (13) | | | | | |
| | | | | | | |
| | | | | | | |
Other | (1) | | | 1 | | | | | |
Ending balance | 52,891 | | | 50,592 | | | | | |
Unearned ESOP Shares | | | | | | | |
Beginning balance | (28) | | | (38) | | | | | |
Common stock plans activity | 2 | | | 2 | | | | | |
Ending balance | (26) | | | (36) | | | | | |
Accumulated Other Comprehensive Loss | | | | | | | |
Beginning balance | (2,018) | | | (1,915) | | | | | |
Other comprehensive income (loss), net of tax | 29 | | | (200) | | | | | |
| | | | | | | |
Ending balance | (1,989) | | | (2,115) | | | | | |
Noncontrolling Interest | | | | | | | |
Beginning balance | 1,546 | | | 1,596 | | | | | |
Net income | 55 | | | 23 | | | | | |
Less: Redeemable noncontrolling interest net income | (2) | | | (1) | | | | | |
| | | | | | | |
Dividends attributable to noncontrolling interest | (44) | | | (64) | | | | | |
Purchase of subsidiary shares from noncontrolling interest, net | — | | | (19) | | | | | |
Disposition of noncontrolling interest, net | (3) | | | (11) | | | | | |
| | | | | | | |
| | | | | | | |
Ending balance | 1,552 | | | 1,524 | | | | | |
Equity at March 31 | $ | 74,347 | | | $ | 73,986 | | | | | |
Supplemental share information |
Shares of common stock issued under employee plans, net | 820 | | | 1,817 | | | | | |
Shares of common stock repurchased | 5,918 | | | 7,883 | | | | | |
Dividends declared per share of common stock | $ | 0.550 | | | $ | 0.510 | | | | | |
| | | | | | | |
See accompanying Notes to Condensed Consolidated Financial Statements
RAYTHEON TECHNOLOGIES CORPORATION
AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1: Basis of Presentation
The Condensed Consolidated Financial Statements at March 31, 2023 and for the quarters ended March 31, 2023 and 2022 are unaudited, and in the opinion of management include adjustments of a normal recurring nature necessary for a fair statement of the results for the interim periods. The results reported in these Condensed Consolidated Financial Statements should not necessarily be taken as indicative of results that may be expected for the entire year. The financial information included herein should be read in conjunction with the financial statements and notes in our 2022 Annual Report on Form 10-K.
We reclassified certain immaterial prior period amounts within the Condensed Consolidated Statement of Cash Flows to conform to our current period presentation.
Raytheon Intelligence & Space (RIS) and Raytheon Missiles & Defense (RMD) follow a 4-4-5 fiscal calendar while Collins Aerospace (Collins) and Pratt & Whitney use a quarter calendar end. Throughout this Quarterly Report on Form 10-Q, when we refer to the quarters ended March 31, 2023 and 2022 with respect to RIS or RMD, we are referring to their April 2, 2023 and April 3, 2022 fiscal quarter ends, respectively.
Unless the context otherwise requires, the terms “we,” “our,” “us,” “the Company,” “Raytheon Technologies,” and “RTC” mean Raytheon Technologies Corporation and its subsidiaries.
The Company recently announced its intention to streamline the structure of its core businesses into three principal business segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The Company plans to implement the reorganization beginning in July 2023. All segment information included in this Form 10-Q is reflective of the existing four segments of Collins, Pratt & Whitney, RIS, and RMD in accordance with the management structure in place as of March 31, 2023.
Russia Sanctions. In response to the Russian military’s invasion of Ukraine on February 24, 2022, the U.S. government and the governments of various jurisdictions in which we operate, including Canada, the United Kingdom, the European Union, and others, have imposed broad economic sanctions and export controls targeting specific industries, entities, and individuals in Russia. The Russian government has implemented similar counter-sanctions and export controls targeting specific industries, entities, and individuals in the U.S. and other jurisdictions in which we operate, including certain members of the Company’s management team and Board of Directors. These government measures, among other limitations, restrict transactions involving various Russian banks and financial institutions and impose enhanced export controls limiting transfers of various goods, software, and technologies to and from Russia, including broadened export controls specifically targeting the aerospace sector. These measures have adversely affected, and could continue to adversely affect, the Company and/or our supply chain, business partners, or customers. As a result of these sanctions on Russia and export controls, in the first quarter of 2022, we recorded pretax charges of $290 million, $210 million net of tax, and the impact of noncontrolling interest, within our Collins and Pratt & Whitney businesses primarily related to increased estimates for credit losses on both our accounts receivables and contract assets, inventory reserves and purchase order obligations, impairment of customer financing assets for products under lease, impairment of contract fulfillment costs that are no longer recoverable, and a loss on the exit of our investment in a Russia-based joint venture. We will continue to monitor future developments, including additional sanctions and other measures, that could adversely affect the Company and/or our supply chain, business partners, or customers.
Coronavirus Disease 2019 (COVID-19) Pandemic. The COVID-19 pandemic caused continuing negative effects on the global economy, our business and operations, the labor market, supply chains, inflation, and the industries in which we operate. Commercial air travel continues to recover to varying degrees. While we believe that the long-term outlook for the aerospace industry remains positive due to the fundamental drivers of air travel demand, uncertainty continues with respect to when commercial air traffic capacity will fully return to and/or exceed pre-pandemic levels. Our expectations regarding the negative effects of the COVID-19 pandemic and ongoing recovery and their potential financial impact are based on available information and assumptions that we believe are reasonable at this time; however, the actual financial impact is highly uncertain and subject to a wide range of factors and future developments.
Note 2: Acquisitions, Dispositions, Goodwill and Intangible Assets
Goodwill. Changes in our goodwill balances for the quarter ended March 31, 2023 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | |
(dollars in millions) | Balance as of December 31, 2022 | | Acquisitions and Divestitures | | | | Foreign Currency Translation and Other | | Balance as of March 31, 2023 |
Collins Aerospace | $ | 30,719 | | | $ | — | | | | | $ | 65 | | | $ | 30,784 | |
Pratt & Whitney | 1,563 | | | — | | | | | — | | | 1,563 | |
Raytheon Intelligence & Space | 9,841 | | | — | | | | | — | | | 9,841 | |
Raytheon Missiles & Defense | 11,700 | | | — | | | | | (1) | | | 11,699 | |
Total Segments | 53,823 | | | — | | | | | 64 | | | 53,887 | |
Eliminations and other | 17 | | | — | | | | | — | | | 17 | |
Total | $ | 53,840 | | | $ | — | | | | | $ | 64 | | | $ | 53,904 | |
Intangible Assets. Identifiable intangible assets are comprised of the following:
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2023 | | December 31, 2022 |
(dollars in millions) | Gross Amount | | Accumulated Amortization | | Gross Amount | | Accumulated Amortization |
Amortized: | | | | | | | |
| | | | | | | |
| | | | | | | |
Collaboration assets | $ | 5,595 | | | $ | (1,470) | | | $ | 5,536 | | | $ | (1,408) | |
Exclusivity assets | 3,002 | | | (325) | | | 2,911 | | | (323) | |
Developed technology and other | 1,204 | | | (567) | | | 1,202 | | | (544) | |
Customer relationships | 29,788 | | | (9,394) | | | 29,775 | | | (8,967) | |
| 39,589 | | | (11,756) | | | 39,424 | | | (11,242) | |
Indefinite-lived: | | | | | | | |
Trademarks and other | 8,644 | | | — | | | 8,641 | | | — | |
Total | $ | 48,233 | | | $ | (11,756) | | | $ | 48,065 | | | $ | (11,242) | |
Amortization of intangible assets for the quarters ended March 31, 2023 and 2022 was $509 million and $487 million, respectively. The following is the expected amortization of intangible assets for the remainder of 2023 through 2028:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(dollars in millions) | | Remaining 2023 | | 2024 | | 2025 | | 2026 | | 2027 | | 2028 |
Amortization expense | | $ | 1,539 | | | $ | 2,183 | | | $ | 2,072 | | | $ | 1,986 | | | $ | 1,870 | | | $ | 1,765 | |
Note 3: Earnings Per Share | | | | | | | | | | | | | | | |
| Quarter Ended March 31, | | |
(dollars and shares in millions, except per share amounts) | 2023 | | 2022 | | | | |
Net income attributable to common shareowners: | | | | | | | |
Income from continuing operations | $ | 1,426 | | | $ | 1,103 | | | | | |
Loss from discontinued operations | — | | | (19) | | | | | |
Net income attributable to common shareowners | $ | 1,426 | | | $ | 1,084 | | | | | |
Basic weighted average number of shares outstanding | 1,462.2 | | | 1,486.8 | | | | | |
Stock awards and equity units (share equivalent) | 12.0 | | | 11.1 | | | | | |
Diluted weighted average number of shares outstanding | 1,474.2 | | | 1,497.9 | | | | | |
Earnings (Loss) Per Share attributable to common shareowners - Basic: | | | | | | | |
Income from continuing operations | $ | 0.98 | | | $ | 0.74 | | | | | |
Loss from discontinued operations | — | | | (0.01) | | | | | |
Net income attributable to common shareowners | $ | 0.98 | | | $ | 0.73 | | | | | |
Earnings (Loss) Per Share attributable to common shareowners - Diluted: | | | | | | | |
Income from continuing operations | $ | 0.97 | | | $ | 0.74 | | | | | |
Loss from discontinued operations | — | | | (0.02) | | | | | |
Net income attributable to common shareowners | $ | 0.97 | | | $ | 0.72 | | | | | |
The computation of diluted earnings per share (EPS) excludes the effect of the potential exercise of stock awards, including stock appreciation rights and stock options, when the average market price of the common stock is lower than the exercise price of the related stock awards during the period because the effect would be anti-dilutive. In addition, the computation of diluted EPS excludes the effect of the potential release or exercise of stock awards when the awards’ assumed proceeds exceed the average market price of the common shares during the period. For the quarters ended March 31, 2023 and 2022, the number of stock awards excluded from the computation was 4.1 million and 7.5 million, respectively.
Note 4: Changes in Contract Estimates at Completion
We review our Estimates at Completion (EACs) at least annually or when a change in circumstances warrants a modification to a previous estimate. For significant contracts, we review our EACs more frequently. Due to the nature of the work required to be performed on many of the Company’s performance obligations, the estimation of total revenue and cost at completion is complex, subject to many variables and requires significant judgment by management on a contract by contract basis. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities, and the related changes in estimates of revenues and costs. The risks and opportunities relate to management’s judgment about the ability and cost to achieve the schedule, consideration of customer-directed delays or reductions in scheduled deliveries, technical requirements, customer activity levels, such as flight hours or aircraft landings, and related variable consideration. Management must make assumptions and estimates regarding contract revenue and costs, including estimates of labor productivity and availability, the complexity and scope of the work to be performed, the availability and cost of materials including any impact from rising costs or inflation, the length of time to complete the performance obligation, execution by our subcontractors, the availability and timing of funding from our customer, overhead cost rates, and current and past maintenance cost and frequency driven by estimated aircraft and engine utilization and estimated useful lives of components, among others. In particular, fixed-price development programs involve significant management judgment, as development contracts by nature have elements that have not been done before and thus, are highly subject to future unexpected cost changes. Cost estimates may also include the estimated cost of satisfying our industrial cooperation agreements, sometimes in the form of either offset obligations or in-country industrial participation (ICIP) agreements, required under certain contracts. These obligations may or may not be distinct depending on their nature. If cash is paid to a customer to satisfy our offset obligations it is recorded as a reduction in the transaction price.
Changes in estimates of net sales, cost of sales and the related impact to operating profit on contracts recognized over time are recognized on a cumulative catch-up basis, which recognizes the cumulative effect of the profit changes on current and prior periods based on a performance obligation’s percentage of completion in the current period. A significant change in one or more of these estimates could affect the profitability of one or more of our performance obligations. Our EAC adjustments also include the establishment of and changes to loss provisions for our contracts accounted for on a percentage of completion basis.
Net EAC adjustments had the following impact on our operating results:
| | | | | | | | | | | | | | | | | | |
| | Quarter Ended March 31, | | |
(dollars in millions, except per share amounts) | | 2023 | | 2022 | | | | |
Total net sales | | $ | (40) | | | $ | 97 | | | | | |
Operating profit | | (124) | | | 36 | | | | | |
Income from continuing operations attributable to common shareowners(1) | | (98) | | | 28 | | | | | |
Diluted earnings per share from continuing operations attributable to common shareowners (1) | | $ | (0.07) | | | $ | 0.02 | | | | | |
(1) Amounts reflect a U.S. statutory tax rate of 21%, which approximates our tax rate on our EAC adjustments.
Note 5: Accounts Receivable, Net
Accounts receivable, net consisted of the following:
| | | | | | | | | | | |
(dollars in millions) | March 31, 2023 | | December 31, 2022 |
Accounts receivable | $ | 10,460 | | | $ | 9,560 | |
Allowance for expected credit losses | (391) | | | (452) | |
Total accounts receivable, net | $ | 10,069 | | | $ | 9,108 | |
Note 6: Contract Assets and Liabilities
Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. We receive payments from customers based on the terms established in our contracts. Total contract assets and contract liabilities were as follows:
| | | | | | | | | | | |
(dollars in millions) | March 31, 2023 | | December 31, 2022 |
Contract assets | $ | 12,729 | | | $ | 11,534 | |
Contract liabilities | (14,870) | | | (14,598) | |
Net contract liabilities | $ | (2,141) | | | $ | (3,064) | |
Contract assets increased $1,195 million during the quarter ended March 31, 2023 primarily due to sales in excess of billings on certain contracts at RMD, Pratt & Whitney, and RIS. Contract liabilities increased $272 million during the quarter ended March 31, 2023 primarily due to billings in excess of sales on certain contracts at Pratt & Whitney and RMD. We recognized revenue of $1.9 billion during the quarter ended March 31, 2023, related to contract liabilities as of January 1, 2023 and $1.8 billion during the quarter ended March 31, 2022, related to contract liabilities as of January 1, 2022.
As of March 31, 2023, our Contract liabilities include approximately $395 million of advance payments received from a Middle East customer on contracts for which we no longer believe we will be able to execute on or obtain required regulatory approvals. These advance payments may become refundable to the customer if the contracts are ultimately terminated.
Contract assets include an allowance for credit losses of $330 million and $318 million as of March 31, 2023 and December 31, 2022, respectively.
Note 7: Inventory, net
Inventory, net consisted of the following:
| | | | | | | | | | | |
(dollars in millions) | March 31, 2023 | | December 31, 2022 |
Raw materials | $ | 3,841 | | | $ | 3,477 | |
Work-in-process | 3,994 | | | 3,839 | |
Finished goods | 3,492 | | | 3,301 | |
Total inventory, net | $ | 11,327 | | | $ | 10,617 | |
Note 8: Borrowings and Lines of Credit
As of March 31, 2023, we had revolving credit agreements with various banks permitting aggregate borrowings of up to $7.0 billion, consisting of a $5.0 billion revolving credit agreement, which expires in April 2025, and a $2.0 billion revolving
credit agreement, which expires in September 2023. As of March 31, 2023, there were no borrowings outstanding under these agreements.
From time to time, we use commercial paper borrowings for general corporate purposes, including the funding of potential acquisitions, pension contributions, debt refinancing, dividend payments, and repurchases of our common stock. The commercial paper notes have original maturities of not more than 364 days from the date of issuance. As of March 31, 2023, our maximum commercial paper borrowing limit was $5.0 billion as the commercial paper is backed by our $5.0 billion revolving credit agreement. We had $100 million and $524 million of commercial paper outstanding at March 31, 2023 and December 31, 2022, respectively, which is reflected in Short-term borrowings in our Condensed Consolidated Balance Sheet. At March 31, 2023 and December 31, 2022, short-term commercial paper borrowings outstanding had a weighted-average interest rate of 4.3% and 4.4%, respectively.
During the quarter ended March 31, 2023, we had no new commercial paper borrowings with maturities greater than 90 days. During the quarter ended March 31, 2023, we made $100 million in repayments of commercial paper with maturities greater than 90 days. During the quarter ended March 31, 2022, we had no commercial paper borrowings or repayments with original maturities more than 90 days from the date of issuance.
There were no repayments of long-term debt during the quarters ended March 31, 2023 and 2022, and there were no issuances of long-term debt during the quarter ended March 31, 2022. We had the following issuances of long-term debt during the quarter ended March 31, 2023:
| | | | | | | | | |
Issuance Date | Description of Notes | Aggregate Principal Balance (in millions) | |
February 27, 2023 | 5.000% notes due 2026 | $ | 500 | | |
| 5.150% notes due 2033 | 1,250 | | |
| 5.375% notes due 2053 | 1,250 | | |
| | |
Long-term debt consisted of the following:
| | | | | | | | | | | |
(dollars in millions) | March 31, 2023 | | December 31, 2022 |
| | | |
| | | |
| | | |
| | | |
3.650% notes due 2023 (1) | $ | 171 | | | $ | 171 | |
3.700% notes due 2023 (1) | 400 | | | 400 | |
3.200% notes due 2024 (1) | 950 | | | 950 | |
3.150% notes due 2024 (1) | 300 | | | 300 | |
3.950% notes due 2025 (1) | 1,500 | | | 1,500 | |
2.650% notes due 2026 (1) | 719 | | | 719 | |
5.000% notes due 2026 (1) | 500 | | | — | |
3.125% notes due 2027 (1) | 1,100 | | | 1,100 | |
3.500% notes due 2027 (1) | 1,300 | | | 1,300 | |
7.200% notes due 2027 (1) | 382 | | | 382 | |
7.100% notes due 2027 | 135 | | | 135 | |
6.700% notes due 2028 | 285 | | | 285 | |
7.000% notes due 2028 (1) | 185 | | | 185 | |
4.125% notes due 2028 (1) | 3,000 | | | 3,000 | |
7.500% notes due 2029 (1) | 414 | | | 414 | |
2.150% notes due 2030 (€500 million principal value) (1) | 537 | | | 531 | |
2.250% notes due 2030 (1) | 1,000 | | | 1,000 | |
1.900% notes due 2031 (1) | 1,000 | | | 1,000 | |
2.375% notes due 2032 (1) | 1,000 | | | 1,000 | |
5.150% notes due 2033 (1) | 1,250 | | | — | |
5.400% notes due 2035 (1) | 446 | | | 446 | |
6.050% notes due 2036 (1) | 410 | | | 410 | |
6.800% notes due 2036 (1) | 117 | | | 117 | |
7.000% notes due 2038 | 148 | | | 148 | |
| | | | | | | | | | | |
6.125% notes due 2038 (1) | 575 | | | 575 | |
4.450% notes due 2038 (1) | 750 | | | 750 | |
5.700% notes due 2040 (1) | 553 | | | 553 | |
4.875% notes due 2040 (1) | 600 | | | 600 | |
4.700% notes due 2041 (1) | 425 | | | 425 | |
4.500% notes due 2042 (1) | 3,500 | | | 3,500 | |
4.800% notes due 2043 (1) | 400 | | | 400 | |
4.200% notes due 2044 (1) | 300 | | | 300 | |
4.150% notes due 2045 (1) | 850 | | | 850 | |
3.750% notes due 2046 (1) | 1,100 | | | 1,100 | |
4.050% notes due 2047 (1) | 600 | | | 600 | |
4.350% notes due 2047 (1) | 1,000 | | | 1,000 | |
4.625% notes due 2048 (1) | 1,750 | | | 1,750 | |
3.125% notes due 2050 (1) | 1,000 | | | 1,000 | |
2.820% notes due 2051 (1) | 1,000 | | | 1,000 | |
3.030% notes due 2052 (1) | 1,100 | | | 1,100 | |
5.375% notes due 2053 (1) | 1,250 | | | — | |
Other (including finance leases) | 252 | | | 253 | |
Total principal long-term debt | 34,254 | | | 31,249 | |
Other (fair market value adjustments, (discounts)/premiums, and debt issuance costs) | 8 | | | 40 | |
Total long-term debt | 34,262 | | | 31,289 | |
Less: current portion | 1,545 | | | 595 | |
Long-term debt, net of current portion | $ | |